DSM-Firmenich AG DSFIR
SIX · Switzerland · Consumer Non-Durables
CHF 89.85-3.20 (-3.44%)
Market closed· · CHF · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · CHF · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Press Release dsm-firmenich completes €540 million share repurchase program Kaiseraugst (Switzerland), Maastricht (Netherlands), October 1, 2026 dsm-firmenich, innovators in nutrition, health, and beauty, announces it has completed its €540 million share repurchase program. On March 12, 2026, the company announced the start of the program for a total amount of €540 million, of which €40 million to cover commitments under the Group’s share-based compensation plans and €500 million to reduce its i
Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), September 29, 2026 dsm-firmenich, innovators in nutrition, health, and beauty, announced on February 9, 2026 its intention to repurchase ordinary shares with an aggregate market value of €500 million and reduce its issued capital. On March 12, 2026, the company commenced repurchasing ordinary shares for a total amount of €540 million, of which €40
Here is how Anheuser-Busch Inbev (BUD) and DSM Firmenich AG - Sponsored ADR (DSFIY) have performed compared to their sector so far this year.
The pursuit of healthy, resilient and flawless-looking skin is redefining beauty innovation across Asia Pacific. As consumer expectations continue to evolve, dsm-firmenich Beauty & Care is advancing epidermal science through CORNEOCARE™ 2.0, a holistic platform that highlight new scientific insights and ingredient innovations that address two highly relevant skin care needs in the region: Sensitive Skin and Flawless Skin.
Press Release Ad hoc announcement pursuant to article 53 LR dsm-firmenich Board of Directors proposes Richard Ridinger as new Chairman following Thomas Leysen’s decision to retire Kaiseraugst (Switzerland), Maastricht (Netherlands), August 18, 2026 dsm-firmenich, innovators in nutrition, health, and beauty, today announces that Thomas Leysen, Chair of the Board of Directors, has decided to retire from the Board. Considering that the merger is now fully completed and strategic direction is set, T
The recent spate of suppliers’ results shows the category remains robust.
Press Release Ad hoc announcement pursuant to article 53 LR Kaiseraugst (Switzerland), Maastricht (Netherlands), July 30, 2026 dsm-firmenich reports H1 2026 resultsGood LFL sales growth and sequential margin improvement through first half Highlights Good like-for-like (LFL) sales growth of 5% in H1 2026, with 6% in Q2Adjusted EBITDA margin improved sequentially, with positive momentum into second halfContinued improvement in adjusted gross operating free cash flow2026-2028 action plan, aimed at
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.